Sign in
ANPC Stock Price, Chart, Stats & News
AnPac Bio-Medical Science Co., Ltd.
Save
26.97M
Market cap
–
Current P/E
–
Forward P/E
ANPC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.21% |
Operating margin | -698.59% |
Pretax margin | -877.85% |
Net margin | -860.16% |
Effective tax rate | 2.01% |
ROA | -255.99% |
ROE | 1140.01% |
D/E | -0.90x |
Interest coverage ratio | -225.57x |
ANPC valuation
P/E | – |
P/S | 15.48x |
P/B | -4.15x |
P/CF | -1.03x |
P/FCF | -3.29x |
P/OCF | -1.03x |
PEG | -0.00x |
EV multiple | -1.77x |
About
AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides these solutions to corporate entities and life insurance companies across the People's Republic of China.
Similar securities
Based on sector and market capitalization
Report issue